Tissue Procurement Core (TPC)


Mark Watson, MD, PhD

The Siteman Cancer Center Tissue Procurement Core provides Washington University researchers and their collaborators with a centralized resource to collect, store and utilize human biospecimens for cancer research. Dedicated staff and facilities are used to generate nucleic acid (DNA and RNA) and histological sections from collected patient specimens. Technologies to facilitate tissue-based translational research such as laser capture microdissection and tissue microarray construction are also available. An archive of over 23,000 snap-frozen biospecimens (tumor tissue, non-malignant tissue, serum, plasma) and corresponding de-identified pathology and demographic data from patients with a variety of solid and hematologic malignancies are available for IRB-approved investigator studies.

LOCATION: BJC Institute of Health, 5th floor, Rms. 5120, 5113, 5205

PRICING: Please contact the core for current pricing of services offered.

TO ACCESS: Call 314-454-7615 or e-mail

Request Biospecimens or Services from the TPC (User Account Required):

Browse Existing Collections of Biospecimens using the WUSTL Biospecimen Navigator (WBN):

NIH PUBLIC ACCESS POLICY: As of April 7, 2008, the NIH requires investigators with a publication using Siteman (or other NIH-funded) shared resources to submit (or have submitted for them) their final, peer reviewed manuscripts to PubMed Central(PMC) upon acceptance of publication, to be made publicly available within 12 months of publication. Many journals automatically submit these for authors, but Washington University also has assistance available through the Becker Medical Library. Please see or for more information.

PUBLICATION ACKNOWLEDGEMENT: If research supported by the Tissue Procurement Core results in publication, please acknowledge this support by including the following in your publication(s):

We thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, MO. and the Institute of Clinical and Translational Sciences (ICTS) at Washington University in St. Louis, for the use of the Tissue Procurement Core, which provided __________ service. The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant #P30 CA091842 and the ICTS is funded by the National Institutes of Health’s NCATS Clinical and Translational Science Award (CTSA) program grant #UL1 TR002345.